Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$63K
+13.3% from 2023
Prescriptions
373
$170.13 per claim
Patients
183
167 prescribers
Total spending, 2024
$63K
$346.76 per patient
Medicare prescription drug plans paid $63K for Clindamycin-0.9% Nacl in 2024, for 373 prescriptions and refills to 183 patients (up 13.3% from 2023). The average cost per claim was $170.13.
New York had the highest Medicare cost for Clindamycin-0.9% Nacl in 2024: $16K for 95 claims, followed by Florida ($14K).
Anthony A Perszyk, medical genetics and genomics in Ponte Vedra Beach, FL, had the highest Medicare cost for Clindamycin-0.9% Nacl in 2024: 27 claims costing $8,735.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Anthony A Perszyk Ponte Vedra Beach, FL | Medical Genetics and Genomics | 27 | Under 11 | $8,735 |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 98 | 200 | 102 | $24K |
| 2023 | 144 | 398 | 149 | $56K |
| 2024 | 167 | 373 | 183 | $63K |
Spending by manufacturer as listed in the spending data
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Manufacturer | Claims | Spending |
|---|---|---|
| Baxter Healthca | 373 | $63K |